- [1] Chang, Yingjie. Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 279, 2024.
- [2] Liang, Tao. Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 221, 113526, 2021.
- [3] Zhao, Yunpeng. Design, synthesis and bioactivity evaluations of 8-substituted-quinoli- ne-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors. Bioorganic & medicinal chemistry, 85, 2023.
- [4] Liang, Tao. Potential applications of BPFP1 in Bcl-2 protein quantification, carcinoma cell visualization, cell sorting and early cancer diagnosis. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 224, 113725, 2021.
- [5] Liu, Meng. Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death. Journal of Medicianal Chemistry, 2024.
- [6] 邱雪婷. An in-line method for high-throughput screening of protein tyrosine phosphatase receptor type O inhibitors by capillary electrophoresis based on electrophoretically mediated microanalysis. Journal of chromatography A, 1713, 2024.
- [7] 聂义明. Development of QSRR model for hydroxamic acids using PCA-GA-BP algorithm incorporated with molecular interaction-based features. FRONTIERS IN CHEMISTRY, 2022.
- [8] 侯旭奔. Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity. Journal of Medicinal Chemistry, 2022.
- [9] 梁翰之. Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer. FRONT PHARMACOL, 13, 864342, 2022.
- [10] 汪铃. Boronate-Based Fluorescent Probes as a Prominent Tool for H2 O2 Sensing and Recognition. Curr Med Chem, 29, 2476, 2022.
- [11] 陈晨. Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity. Journal of Medicinal Chemistry, 65, 3667, 2022.
- [12] 梁涛. Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 221, 2021.
- [13] 梁涛. Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 221, 2021.
- [14] 梁涛. Potential applications of BPFP1 in Bcl-2 protein quantification, carcinoma cell visualization, cell sorting and early cancer diagnosis.. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021.
- [15] 李佳. Synthesis and evaluation of a UMI-77-based fluorescent probe for selective detecting Mcl-1 protein and imaging in living cancer cells. BIOORGANIC & MEDICINAL CHEMISTRY Journal, 29, 2021.
- [16] 杨越. Enantioseparation of lysine derivatives on amylose tris (3, 5-dimethylphenylcarbamate) as chiral stationary phase with high separation factor. Journal of Chromatography A, 1632, 2020.
- [17] 周易. Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma. 《Journal of Medicinal Chemistry》, 63, 4701, 2020.
- [18] 梁涛. HDAC-Bax Multiple Ligands Enhance Bax-Dependent Apoptosis in HeLa Cells. 《Journal of Medicinal Chemistry》, 63, 12083, 2020.
- [19] 侯旭奔 and 方浩. Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors. EUR J MED CHEM, 191, 2020.
- [20] 方浩 , 方浩 and 杨新颖. N9 位芳基取代嘌呤-8-酮类衍生物的合成及抗肿瘤活性. CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2019.
杨新颖 (高级实验师)
高级实验师
性别：女
在职信息：在职
所在单位：药学院
入职时间：2005-04-05
所属院系： 齐鲁医学院 , 药学院 , 药学院 , 药学院
访问量：
最后更新时间：..
最后更新时间：..